Free β-hCG (ng/ml) | PAPP-A (mIU/ml) | ||||||
---|---|---|---|---|---|---|---|
Sample | Control Module LFBCM | Human serum | Control Module LPCCM | Human serum | |||
Control 1 | Control 2 | Control 3 | Control 1 | Control 2 | |||
Target | 5.1 | 23.8 | 74.2 | 0.40 | 1.96 | ||
2SD Range | (4.2-6.4) | (19.8-27.8) | (63.6-90.8) | (0.32-0.48) | (1.70-2.22) | ||
Within-run | |||||||
Mean | 4.84 | 24.1 | 72.8 | 66.6 | 0.41 | 1.94 | 2.58 |
SD | 0.15 | 1.12 | 3.50 | 2.40 | 0.01 | 0.06 | 0.17 |
CV* (%) | 3.09 | 4.65 | 4.81 | 3.60 | 2.44 | 3.09 | 6.59 |
Between-run | |||||||
Mean | 4.75 | 22.66 | 71.66 | 61.7 | 0.38 | 1.94 | 2.39 |
SD | 0.31 | 1.70 | 5.25 | 4.13 | 0.02 | 0.11 | 0.21 |
CV* (%) | 6.52 | 7.50 | 7.32 | 6.69 | 5.26 | 5.67 | 8.79 |